Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fortunato Morabito

Showing results (201-210 of 302) with videos related to

Pageof 31
Sort By:
European Journal of Haematology|June 23, 2026
Extranodal Marginal Zone Lymphoma: Integrating Etiology, Microenvironment, and Genetics Into Clinical Decision-MakingMamdouh Skafi, Santino Caserta, Enrica Antonia Martino, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 3, 2013
Igs expressed by chronic lymphocytic leukemia B cells show limited binding-site structure variabilityPaolo Marcatili, Fabio Ghiotto, Claudya Tenca, et al.
Frontiers in Oncology|September 18, 2023
Genes selection using deep learning and explainable artificial intelligence for chronic lymphocytic leukemia predicting the need and time to therapyFortunato Morabito, Carlo Adornetto, Paola Monti, et al.
Cell Reports|March 17, 2021
Human pluripotent stem cells identify molecular targets of trisomy 12 in chronic lymphocytic leukemia patientsJennifer C Reid, Diana Golubeva, Allison L Boyd, et al.
Leukemia & Lymphoma|July 2, 2011
Cytological and histological detection of amyloid deposits in bone marrow of patients affected by multiple myelomaFara Petruzziello, Pio Zeppa, Giuseppe Ciancia, et al.
Molecular Medicine (Cambridge, Mass.)|July 26, 2011
Mutation pattern of paired immunoglobulin heavy and light variable domains in chronic lymphocytic leukemia B cellsFabio Ghiotto, Paolo Marcatili, Claudya Tenca, et al.
Expert Opinion on Investigational Drugs|January 11, 2011
Lenalidomide in the treatment of chronic lymphocytic leukemiaMassimo Gentile, Anna Grazia Recchia, Ernesto Vigna, et al.
Expert Opinion on Investigational Drugs|December 7, 2010
Janus kinase 2 inhibitors in myeloproliferative disordersEugenio Lucia, Anna Grazia Recchia, Massimo Gentile, et al.
Leukemia Research|March 16, 2017
Clinical relevance of hypogammaglobulinemia, clinical and biologic variables on the infection risk and outcome of patients with stage A chronic lymphocytic leukemiaFrancesca R Mauro, Fortunato Morabito, Iolanda D Vincelli, et al.
Clinical Lymphoma & Myeloma|May 2, 2009
Melphalan, prednisone, and lenalidomide for newly diagnosed myeloma: kinetics of neutropenia and thrombocytopenia and time-to-event resultsAntonio Palumbo, Patrizia Falco, Antonietta Falcone, et al.
Pageof 31

Showing results (201-210 of 302) with videos related to

Sort By:
Pageof 31
European Journal of Haematology|June 23, 2026
Extranodal Marginal Zone Lymphoma: Integrating Etiology, Microenvironment, and Genetics Into Clinical Decision-MakingMamdouh Skafi, Santino Caserta, Enrica Antonia Martino, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 3, 2013
Igs expressed by chronic lymphocytic leukemia B cells show limited binding-site structure variabilityPaolo Marcatili, Fabio Ghiotto, Claudya Tenca, et al.
Frontiers in Oncology|September 18, 2023
Genes selection using deep learning and explainable artificial intelligence for chronic lymphocytic leukemia predicting the need and time to therapyFortunato Morabito, Carlo Adornetto, Paola Monti, et al.
Cell Reports|March 17, 2021
Human pluripotent stem cells identify molecular targets of trisomy 12 in chronic lymphocytic leukemia patientsJennifer C Reid, Diana Golubeva, Allison L Boyd, et al.
Leukemia & Lymphoma|July 2, 2011
Cytological and histological detection of amyloid deposits in bone marrow of patients affected by multiple myelomaFara Petruzziello, Pio Zeppa, Giuseppe Ciancia, et al.
Molecular Medicine (Cambridge, Mass.)|July 26, 2011
Mutation pattern of paired immunoglobulin heavy and light variable domains in chronic lymphocytic leukemia B cellsFabio Ghiotto, Paolo Marcatili, Claudya Tenca, et al.
Expert Opinion on Investigational Drugs|January 11, 2011
Lenalidomide in the treatment of chronic lymphocytic leukemiaMassimo Gentile, Anna Grazia Recchia, Ernesto Vigna, et al.
Expert Opinion on Investigational Drugs|December 7, 2010
Janus kinase 2 inhibitors in myeloproliferative disordersEugenio Lucia, Anna Grazia Recchia, Massimo Gentile, et al.
Leukemia Research|March 16, 2017
Clinical relevance of hypogammaglobulinemia, clinical and biologic variables on the infection risk and outcome of patients with stage A chronic lymphocytic leukemiaFrancesca R Mauro, Fortunato Morabito, Iolanda D Vincelli, et al.
Clinical Lymphoma & Myeloma|May 2, 2009
Melphalan, prednisone, and lenalidomide for newly diagnosed myeloma: kinetics of neutropenia and thrombocytopenia and time-to-event resultsAntonio Palumbo, Patrizia Falco, Antonietta Falcone, et al.
Pageof 31